Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Intellia Thera CS (NTLA)

16.70 +1.60 (+10.60%)

6/26/2017  12:59pm

Open:

15.20

Pre. Close:

15.10

High:

16.82

Low:

14.71

Volume:

257,613

Market Cap:

601.67M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

15.73 - 15.99

15.99 - 16.39

Low:

13.57 - 13.87

13.87 - 14.33

Close:

14.65 - 15

15 - 15.51

Technical analysis  (as of: 2017-06-26 12:23:49 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 18.86     One year: 22.03

Support:

Support1: 13.06    Support2: 11.15

Resistance:

Resistance1: 16.15    Resistance2: 18.86

Pivot:

13.34

Moving Averages:

MA(5): 14.97     MA(20): 13.10

MA(100): 13.69     MA(250): 15.60

MACD:

MACD(12,26): 0.40     Signal(12,26,9): -0.02

%K %D:

%K(14,3): 84.62     %D(3): 86.20

RSI:

RSI(14): 66.95

52-Week:

High: 27.20  Low: 10.83  Change(%): -39.5

Average Vol(K):

3-Month: 210  10-Days 370

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
NTLA has closed below upper band by 2.2%. Bollinger Bands are 114% wider than normal. The large width of the bands suggest high volatility as compared to NTLA's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue.

Headline News

Sun, 21 May 2017 00:33:45 GMT
Analysts Expect Intellia Therapeutics Inc (NTLA) to Post -$0.41 EPS

Thu, 27 Oct 2016 00:45:36 GMT
Space is at a premium for Cambridge startup Intellia

Wed, 11 Jan 2017 21:38:59 GMT
Intellia Therapeutics Joins Genomics England's Industry Consortium

Thu, 13 Oct 2016 10:31:55 GMT
Intellia Therapeutics Is A Buy

Mon, 19 Jun 2017 11:26:15 GMT
Intellia Therapeutics Announces Patent for CRISPR/Cas Genome Editing in China

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

36.03

Shares Float (M)

13.13

% Held by Insiders

% Held by Institutions

Shares Short (K)

1540

Shares Short Prior Month (K)

1660

Stock Financials

EPS

-1.220

EPS Est. Current Year

-1.450

EPS Est. Next Year

-1.410

EPS Est. Next Quarter

-0.440

Forward EPS

-1.411

Book Value (p.s.)

5.550

PEG Ratio

Profit Margin

-179.64

Operating Margin

-183.65

Return on Assets (ttm)

-13.5

Return on Equity (ttm)

-28.8

Qtrly Rev. Growth

249.7

Gross Profit (p.s.)

0.457

Sales Per Share

EBITDA (p.s.)

-1.022

Qtrly Earnings Growth

Operating Cash Flow (M)

34.13

Levered Free Cash Flow (M)

-11.05

FoxReading.com

Valuation

P/E

-12.98

P/E Growth Ratio

0.05

P/BV

2.85

P/S

839287104.00

P/CF

16.72

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.